Literature DB >> 16630131

Mouse models of gastrointestinal tumors.

Makoto Mark Taketo1.   

Abstract

The laboratory mouse (Mus musculus) has become one of the best model animal species in biomedical research today because of its abundant genetic/genomic information, and easy mutagenesis using transgenic and gene knockout technology. Genetically engineered mice have become essential tools in both mechanistic studies and drug development. In this article I will review recent topics in gastrointestinal cancer model mice, with emphasis on the results obtained in our laboratory. They include: (i) mouse models for familial adenomatous polyposis (Apc mutant mice; modifier genes of Apc intestinal polyposis; stabilizing beta-catenin mutant mice); (ii) mouse models for colon cancer (mouse models for hereditary non-polyposis colon cancer; additional mutations in Apc mutant mice; models with mutations in other genes; models for colon cancer associated with inflammatory bowel diseases); and (iii) mouse models for gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16630131     DOI: 10.1111/j.1349-7006.2006.00190.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  34 in total

1.  Confocal laser endomicroscopy and narrow-band imaging-aided endoscopy for in vivo imaging of colitis and colon cancer in mice.

Authors:  Maximilian J Waldner; Stefan Wirtz; Clemens Neufert; Christoph Becker; Markus F Neurath
Journal:  Nat Protoc       Date:  2011-09-01       Impact factor: 13.491

2.  Suppressor of cytokine signaling-2 gene disruption promotes Apc(Min/+) tumorigenesis and activator protein-1 activation.

Authors:  Victoria A Newton; Nicole M Ramocki; Brooks P Scull; James G Simmons; Kirk McNaughton; P Kay Lund
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

3.  The myc 3' wnt-responsive element suppresses colonic tumorigenesis.

Authors:  Wesley M Konsavage; Gregory S Yochum
Journal:  Mol Cell Biol       Date:  2014-02-24       Impact factor: 4.272

4.  Colon-specific tumorigenesis in mice driven by Cre-mediated inactivation of Apc and activation of mutant Kras.

Authors:  Alexander J Byun; Kenneth E Hung; James C Fleet; Roderick T Bronson; Joel B Mason; Paloma E Garcia; Jimmy W Crott
Journal:  Cancer Lett       Date:  2014-03-14       Impact factor: 8.679

Review 5.  Stem cells and cancer of the stomach and intestine.

Authors:  Robert G J Vries; Meritxell Huch; Hans Clevers
Journal:  Mol Oncol       Date:  2010-06-08       Impact factor: 6.603

Review 6.  Novel translational strategies in colorectal cancer research.

Authors:  Ignacio Gil-Bazo
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

Review 7.  Understanding phenotypic variation in rodent models with germline Apc mutations.

Authors:  Maged Zeineldin; Kristi L Neufeld
Journal:  Cancer Res       Date:  2013-04-11       Impact factor: 12.701

8.  Guidelines for the welfare and use of animals in cancer research.

Authors:  P Workman; E O Aboagye; F Balkwill; A Balmain; G Bruder; D J Chaplin; J A Double; J Everitt; D A H Farningham; M J Glennie; L R Kelland; V Robinson; I J Stratford; G M Tozer; S Watson; S R Wedge; S A Eccles
Journal:  Br J Cancer       Date:  2010-05-25       Impact factor: 7.640

9.  Characterization of three newly established rat sarcoma cell clones.

Authors:  Monika Holubova; Martin Leba; Markéta Sedmikova; Luca Vannucci; Vratislav Horak
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-11-13       Impact factor: 2.416

10.  Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease.

Authors:  Adam E Snook; Peng Li; Benjamin J Stafford; Elizabeth J Faul; Lan Huang; Ruth C Birbe; Alessandro Bombonati; Stephanie Schulz; Matthias J Schnell; Laurence C Eisenlohr; Scott A Waldman
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.